- Category
- Small (2024-25)
- Udyam number
- UDYAM-MP-23-0052445

About Pharma Corp. Inc. Private Limited
Data last updated:
Pharma Corp. Inc. Private Limited is a private limited company based in Indore, Madhya Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 24 November 2008 and has been in existence for over 18 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24230MP2008PTC021361. Its GSTIN is 23AAECP8775E1Z9 (Madhya Pradesh). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It was formerly known as Pharma Corp. Inc. Limited. It is led by directors including Rajesh Kasturi and Rohit Kasturi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No.49 Sk Compound 1 Mr – 11 Lasuria Mori Dewas Naka, Indore, Madhya Pradesh, India – 452010.
As per the financials filed for FY 2025, the company reported a revenue of ₹48.87 Cr, a growth of 10% compared to the previous year. For the same year it recorded a net profit of ₹1.32 Cr (net margin 2.7%) and EBITDA of ₹2.52 Cr (EBITDA margin 5.2%). Revenue has grown at a compounded annual rate (CAGR) of 6% over three years and 2% over five years.
The company is associated with 1 brand: PCI Pharmaceuticals. As per MCA filings, the company has open charges of ₹8.6 Cr on record. Court records list 35 cases involving the company, including 31 filed by the company and 4 filed against it; 20 cases are pending.
Pharma Corp. Inc. Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MP-23-0052445). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website pcipharmaceuticals.com.
Company details
CIN history
Pharma Corp. Inc has one previous CIN (Corporate Identification Number): U24230MP2008PLC021361. The current CIN is U24230MP2008PTC021361, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24230MP2008PTC021361 | Current |
| U24230MP2008PLC021361 | Previous |
Recognitions & Rankings of Pharma Corp. Inc
Contact details
Pharma Corp. Inc. Private Limited's registered office is in Indore, Madhya Pradesh. Its website is pcipharmaceuticals.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressPlot No.49 Sk Compound 1 Mr – 11 Lasuria Mori Dewas Naka, Indore, Madhya Pradesh, India – 452010
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Pharma Corp. Inc. Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Pharma Corp. Inc operates one associated brand: PCI Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical products and services in animal and human health sectors in India. | pcipharmaceuticals.com |
Business activity
The main business activity of Pharma Corp. Inc is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Pharma Corp. Inc. Private Limited, buy the company report.
Financials of Pharma Corp. Inc. Private Limited
FY 2025 filings availablePharma Corp. Inc. Private Limited reported revenue of ₹48.87 Cr (up 10% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 2% over five years, including 10% growth in the latest year. EBITDA fell 4% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.52 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.32 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.2% | ||||
| Net Profit Margin | 2.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Pharma Corp. Inc. Private Limited, buy the company report.
Board of directors of Pharma Corp. Inc. Private Limited
Pharma Corp. Inc has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajesh Kasturi Also directs: Lycon Healthcare LLP, Yes Drugs LLP | Director | 24 Nov 2008 | 17 Years 11 Months | Current |
| Rohit Kasturi | Director | 10 Dec 2011 | 14 Years 10 Months | Current |
| Neeraj Ghanani | Director | 24 Nov 2008 | 17 Years 11 Months | Current |
Peer comparison
Pharma Corp. Inc. Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Lazerhead Lifesciences Private Limited | ₹49.03 Cr (FY 2024) | 3005.0% | Telangana, India | |||
| Rena Exports Private Limited | ₹49.02 Cr (FY 2024) | 38.0% | Mumbai, Maharashtra, India | |||
| Ganapati Bio- Tech Limited | ₹49.01 Cr (FY 2025) | 23.0% | New Delhi, Delhi, India | |||
| Pharma Corp. Inc. Private Limitedthis company | ₹48.87 Cr (FY 2025) | ₹1.32 Cr | 2.7% | 10.0% | Indore, Madhya Pradesh, India | |
| Sundarlal Pharma Distributors Private Limited | ₹48.84 Cr (FY 2025) | 24.0% | Mumbai, Maharashtra, India | |||
| Welcomevet Pharma Private Limited | ₹48.7 Cr (FY 2025) | 4.0% | Lucnow, Uttar Pradesh, India | |||
| Shah Medico Private Limited | ₹48.25 Cr (FY 2025) | 39.0% | Pune, Maharashtra, India | |||
| Fresh Focus Consumer Products Private Limited | ₹48.02 Cr (FY 2025) | -6.0% | Kolkata, West Bengal, India |
To see the full peer comparison of Pharma Corp. Inc. Private Limited, buy the company report.
Auditor
Pharma Corp. Inc. Private Limited is audited by Rajendra Khandelwal & Co for the financial year 2018.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Rajendra Khandelwal & Co | FY 2018 | 113527W |
Shareholding
The shareholding of Pharma Corp. Inc. Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Pharma Corp. Inc. Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 12 Dec 2024 | 101054126 | Hdfc Bank Limited | ₹60 Lakh | Open | |
| 17 Jul 2010 | 10237216 | Ing Vysya Bank Limited | ₹8 Cr | Open |
Total charge records: 2 View all charges
Legal cases
Pharma Corp. Inc. Private Limited has 35 court cases on record: 31 filed by Pharma Corp. Inc, 4 filed against it. 20 cases are pending and 15 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 31 | 4 | 18 |
| High courts | 4 | 0 | 2 |
Cases on record (5 of 35)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Commercial suit | Filed by the company against Pci Bioscience Pvt. Ltd. & Ors. | Pending |
| District court, Indore, Madhya Pradesh | Court case (SC NIA) | Filed by the company against B D Pharmaceutical Works Private Limited | Pending |
| District court, Calcutta, West Bengal | Civil suit | Filed against the company by B.D. Pharma Works Pvt Ltd. | Disposed |
| District court, Solan, Himachal Pradesh | Appeal | Filed by the company against M/S Captab Biotec | Pending |
| High Court of Delhi | Writ petition | Filed by the company against Union of India & Anr. | Pending |
To see the full case history of Pharma Corp. Inc. Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Pharma Corp. Inc. Private Limited has 7 MSME Form 1 returns on record between 2012 and 2020, listing 496 overdue payments to 75 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 75)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Stafford Laboratories Private Limited | |||
| Riemann Labs Private Limited | |||
| an individual supplier | |||
| Super Formulations Private Limited | |||
| Regain Laboratories |
To see the full MSME payment records of Pharma Corp. Inc. Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
GST
Pharma Corp. Inc has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AAECP8775E1Z9 | Madhya Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Pharma Corp. Inc. Private Limited, buy the company report.
Recent activity
Pharma Corp. Inc. Private Limited has 5 board changes on record since 2008: 3 appointments and 2 cessations. The latest: Sanjay Kumar Kasturi ceased to be Director on 10 Aug 2022.
Frequently asked questions
Pharma Corp. Inc is an active private limited company based in Indore, Madhya Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 24 November 2008 (18+ years old) and is registered under CIN U24230MP2008PTC021361.
Pharma Corp. Inc has 3 current directors:
- Rajesh Kasturi - Director
- Rohit Kasturi - Director
- Neeraj Ghanani - Director
The latest financial statements of Pharma Corp. Inc on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Pharma Corp. Inc is 23AAECP8775E1Z9, registered in Madhya Pradesh. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Pharma Corp. Inc is U24230MP2008PTC021361. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Pharma Corp. Inc has 35 court cases on record: 31 filed by the company and 4 filed against it. 20 are pending. Most are in the district courts.
Pharma Corp. Inc was incorporated on 24 November 2008, making it 18+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Pharma Corp. Inc by revenue are Lazerhead Lifesciences Private Limited, Rena Exports Private Limited, Ganapati Bio- Tech Limited, Sundarlal Pharma Distributors Private Limited, Welcomevet Pharma Private Limited and 2 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Sanjay Kumar Kasturi ceased to be Director on 10 Aug 2022. Rohit Kasturi ceased to be Additional Director on 28 Sep 2012. Rohit Kasturi was appointed as Director on 10 Dec 2011. Pharma Corp. Inc has 5 board changes on record in total.
Yes, Pharma Corp. Inc is registered as a small enterprise under Udyam registration (number: UDYAM-MP-23-0052445).
Pharma Corp. Inc has 7 MSME Form 1 returns on record between 2012 and 2020, listing 496 overdue payments to 75 micro and small suppliers. The latest return was filed on 28 Oct 2020.
Pharma Corp. Inc can be reached through the website pcipharmaceuticals.com. Its registered office is in Indore, Madhya Pradesh, India.